Michalopoulou Moscho, Jebb Susan A, MacKillop Lucy H, Dyson Pamela, Hirst Jane E, Zhu Sufen, Wire Amy, Astbury Nerys M
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Diabetes Obes Metab. 2024 Apr;26(4):1407-1420. doi: 10.1111/dom.15442. Epub 2024 Jan 16.
To test the feasibility and acceptability of a reduced-carbohydrate dietary program, intended to reduce the risk of gestational diabetes.
Fifty-one pregnant women at <20 weeks' gestation, with body mass index ≥30 kg/m , and a normal baseline oral glucose tolerance test (OGTT), were randomized 2:1 to an intervention or control group and followed-up until delivery. The dietary intervention aimed at providing 130-150 g carbohydrate/day. Feasibility outcomes assessed at 24-28 weeks' gestation, included adoption of the reduced-carbohydrate diet by the intervention group, and retention of all participants, assessed by completion of a second OGTT. Changes in glycemia, weight gain and dietary intake, and the maternal and neonatal outcomes were also assessed. Participants were interviewed about their experience of the intervention and the study.
Forty-nine of 51 participants attended the follow-up OGTT, a retention rate of 96% (95% confidence interval [CI] 86.8%-98.9%). In the intervention group, carbohydrate intake at follow-up was 190.4 (95% CI 162.5-215.6) g/day, a reduction of -24.6 (95% CI -51.5-2.4) g/day from baseline. Potentially favourable effects of the intervention on glucose control, weight gain and blood pressure were observed, but the study was not powered to detect significant differences in these. Participants found the intervention acceptable, and were content with the study processes, but some reported barriers to sustained adherence, mainly pertaining to competing priorities.
Retention was high, suggesting the study processes are feasible, but the carbohydrate reduction in the intervention group was small, and did not meet progression criteria, limiting the likelihood of achieving the desired goal to prevent gestational diabetes.
ISRCTN16235884.
测试一种低碳水化合物饮食方案的可行性和可接受性,该方案旨在降低妊娠期糖尿病的风险。
51名妊娠小于20周、体重指数≥30kg/m²且口服葡萄糖耐量试验(OGTT)基线正常的孕妇,按2:1随机分为干预组或对照组,并随访至分娩。饮食干预旨在每日提供130 - 150克碳水化合物。在妊娠24 - 28周时评估可行性结果,包括干预组采用低碳水化合物饮食的情况,以及通过第二次OGTT完成情况评估所有参与者的留存率。还评估了血糖、体重增加和饮食摄入的变化以及母婴结局。就参与者对干预和研究的体验进行了访谈。
51名参与者中有49人参加了随访OGTT,留存率为96%(95%置信区间[CI] 86.8% - 98.9%)。干预组随访时碳水化合物摄入量为190.4(95% CI 162.5 - 215.6)克/天,较基线减少了 - 24.6(95% CI - 51.5 - 2.4)克/天。观察到干预对血糖控制、体重增加和血压有潜在的有利影响,但该研究无足够效力检测这些方面的显著差异。参与者认为干预是可接受的,对研究过程也满意,但一些人报告了持续坚持的障碍,主要与相互竞争的优先事项有关。
留存率高,表明研究过程可行,但干预组碳水化合物减少量较小,未达到进展标准,限制了实现预防妊娠期糖尿病预期目标的可能性。
ISRCTN16235884。